Co-beneldopa (Benserazide/levodopa) Prescribing at THE WILLOW GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
816
Total Quantity
103.9K
NHS Cost
£7.7K
vs National Avg
+439.8%
THE WILLOW GROUP prescribed 816 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £7,694 to the NHS. This is 439.8% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
57
Jun 2026
81
Jun 2026
65
Jun 2026
58
Jun 2026
63
Jun 2026
75
Jun 2026
80
Jun 2026
71
Jun 2026
70
Jun 2026
57
Jun 2026
74
Jun 2026
65
Prescribing Details
| Total Items | 816 |
|---|---|
| Total Quantity | 103,900 |
| Total NHS Cost | £7,694 |
| Presentations | 10 different forms |
| vs National Average | +439.8% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 816 items |
|---|---|
| National average per practice | 151 items |
| Difference | +439.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.